Daniel Stram named AAAS Fellow

November 24, 2015

Daniel Stram of the Keck School of Medicine of USC is now a fellow of the American Association for the Advancement of Science, the nonprofit announced Monday.

Stram, a preventive medicine professor in USC's Division of Biostatistics and Genetic Epidemiology, said he was pleasantly surprised to be named a fellow. He has been a member of AAAS for 25 years.

"They listed a lot of different fields that I contributed to," Stram said. "I've tried to solve statistical problems in many areas. It's gratifying to see that the sum total of the work was being honored."

AAAS gave 347 members fellow status in 2015. They were given the honor because of their efforts to advance science or its applications. Stram was selected "for development and application of innovative statistical procedures for laboratory, clinical and field studies, and for signature collaborations in genomics, cancer treatment, and radiation effects."

The AAAS fellows tradition began in 1874. AAAS, the world's largest general scientific society, is publisher of the journal Science, which has an estimated total readership of 1 million, making it the largest paid circulation of any peer-reviewed general science journal in the world.

Stram spent three years in Hiroshima in the late 1980s to work on a health follow-up study of atomic bomb survivors. In that study, he developed risk estimation methods by looking at measurement error in radiation dose estimates. This led to his longstanding interest in the statistical treatment of uncertainty in risk analysis.

"I'm interested in making statistical decisions in the presence of uncertainty in exposures for different diseases," Stram said. "If those exposures are not perfectly measured, then we have an exposure measurement problem. I help address those problems."

Currently, Stram is participating in a long-term study of the occupational and environmental health effects of exposure to plutonium production radiation originating from Russia's Cold War era. He hopes to inform people about cancer risk when radiation exposure rates are extended over a prolonged period of time. Stram also contributes to many epidemiologic and genomics studies at USC.

New fellows will receive an official certificate and gold and blue rosette pin on Feb. 13 at the annual AAAS meeting in Washington, D.C.
-end-


University of Southern California

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.